Eli Adashi
638 posts


Delighted to post the latest publication of ours with @CohenProf (Harvard Law School). This is the story of the LDTs (Laboratory-Developed Tests) and how they were handled by the Trump and Biden Administrations. Most notably, integrity of the LDTs in question was restored.

English

Delighted to post our latest JAMA Viewpoint on the approval and oversight of SARS-CoV-2 Laboratory-Developed Tests. Co-authored with @CohenProf (Harvard Law), the paper details the conflicting approaches of the current and former administration. A sobering story.

English

Delighted to posy our latest contribution on the all-important matter of Transparency and the Doctor-Patient Relationship. Co-authored with Jacob Elberg (Seton Hall Law) and @CohenProf (Harvard Law), the paper explores a rethinking of the Conflict-of-Interest Disclosures.

English

Delighted to post our latest paper on the National Pandemic Preparedness Program. Published in JAMA, the paper, co-authored with @CohenProf (Harvard Law), describes the challenges involved in future pandemic planning & the mixed record of prior efforts along these lines.

English

Delighted to post a recent publication with the Am J of Med. Co-authored with @CohenProf (Harvard Law), the paper highlights the all important role of antiviral therapeutics in the taming of the SARS-CoV-2 pandemic. Recent progress aside, more potent therapeutics are called for.

English

Our latest with Katina M Robison (Brown University) and @CohenProf (Harvard Law). Written in honor of Amy J. Reed, MD, PhD whose tragic premature passing due to a Leiomyosarcoma of the Uterus was universally mourned. Current morcellation practices preclude such outcome.

English

Delighted to post the latest Perspective of ours just published by the New England Journal of Medicine. Co-authored with @pzettler (Ohio State) and @CohenProf (Harvard Law), the paper deals with the all-important distinction between drugs and devices as it pertains to the FDA,.

English











